COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials (4 News)

COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials

Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here’s what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.

“We take molecules and try to develop medicines,” said chief operating officer Brandon Brega. “It’s for our military war fighters and peacekeepers.”

At Ology Bioservices they’ve just sent a monoclonal antibody medicine to clinical trials. In short, it’s a medicine that can fight off COVID-19 for a moderate amount of time.

Learn more about COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials.
Related news Ology Bioservices Awarded $37 Million by Department of Defense for Advanced Development of Anti-COVID-19 Monoclonal Antibody Cocktail.
X